WOLFF WIESE MAGANA LLC: CSR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of WOLFF WIESE MAGANA LLC on CSR, newest first. How the timeline and the estimate are built.
WOLFF WIESE MAGANA LLC held 748 CSR shares at 2026-06-30 per its 13F-HR filed 2026-07-13.
the latest 13F is the newest step
- period ended2026-06-3013F 748 sharesChange vs previous 13F 0 shares
0.02% of the 13F portfolio, value $42,031.
13F-HR 0001832097-26-000003 filed by WOLFF WIESE MAGANA LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 748 sharesChange vs previous 13F 0 shares
0.02% of the 13F portfolio, value $42,973.
13F-HR 0001832097-26-000002 filed by WOLFF WIESE MAGANA LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 748 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $49,907.
13F-HR 0001832097-26-000001 filed by WOLFF WIESE MAGANA LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 748 sharesChange vs previous 13F 0 shares
0.02% of the 13F portfolio, value $44,058.
13F-HR 0001832097-25-000010 filed by WOLFF WIESE MAGANA LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 748 sharesChange vs previous 13F +673 shares
0.03% of the 13F portfolio, value $45,023.
13F-HR 0001832097-25-000008 filed by WOLFF WIESE MAGANA LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 75 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $4,857.
13F-HR 0001832097-25-000005 filed by WOLFF WIESE MAGANA LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).